News | May 11, 2023
AIIA and CCRAS jointly organised session for research and education in Ayush
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
He mentioned that Thyroid disorders are a common health problem in Jammu and Kashmir
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Essex enriches and complements Emmes’ services
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Subscribe To Our Newsletter & Stay Updated
